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Background: In order to sustain the elimination of measles, timely 
reporting is important. We analyzed surveillance data in Korea from 
2002–2009 to determine the effect of sentinel laboratory surveillance 
(SLS), which was introduced in 2006, on the timeliness of measles 
reporting.  
Methods: We stratified data by two surveillance periods, (A) before and 
(B) after 2006, and by clinically-confirmed and laboratory-confirmed 
cases. 
Results: During Period A, 113 suspected cases were reported, and 241 
during Period B. There was no difference in the proportion of timely 
reporting among clinically-confirmed cases between the two periods, 
whereas the proportion of laboratory-confirmed cases has increased. 
The mean notification interval in laboratory-confirmed cases was 
shortened from 39 to 16 days. 
Conclusions: In Korea, SLS has enhanced earlier detection of 
suspected cases that had not been reported, improving the timeliness of 
measles surveillance. Adopting this new method may improve the 
timely collection of cases in other countries as well. 
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Measles is a highly contagious disease that causes substantial disease 
burden in children worldwide. The incidence of measles has been 
declined some countries following the introduction of effective 
vaccination program [1]. However, measles is still a major public 
health threat because of its worldwide prevalence and changing 
epidemiologic pattern in countries where vaccines has been widely 
used [2, 3]. Although it is rare in South Korea presently, hospitalization 
for measles and its complications was common before the widespread 
use of the vaccine [4-6]. Furthermore, severe complications of measles 
can occur in susceptible subjects; in the 1960s, measles was one of the 
10 leading causes of death in Korean children [7]. At the time of the 
installation of the national surveillance system in 1955, the annual 
number of reported measles cases ranged from 9,400 to 30,000; the 
number has been decreasing since the 1960s [8].  
The introduction of measles monovalent vaccine in 1965 and the 
measles-mumps-rubella (MMR) vaccine in 1980 has played an 
important role in the decline in the number of reported cases. However, 
occasional outbreaks in cyclic patterns continued to occur every 3–4 
years, due to poor routine vaccination coverage [9, 10]. Although 1 
dose of MMR vaccine given at 15 months of age was partly introduced 




1990, which affected approximately 5,000 patients, prompted the 
government and academia to take action [11]. During the outbreak, the 
peak incidence occurred among young children; therefore, since 1994, 
the Korean Pediatric Society has recommended that a second dose of 
MMR vaccine should be given at 6 years of age, and the same 
recommendation was issued by the government 3 years later [11-13]. 
Following the recommendation, the number of reported cases had 
decreased to less than 100 cases annually by the late 1990s. However, 
an unexpected nationwide outbreak involving 55,707 cases and 7 
deaths occurred in 2000–2001 [14]. In response, the government 
instituted the Five Year Measles Elimination Program, which included 
the following: (1) a catch-up campaign targeting approximately 5 
million school-aged children; (2) a keep-up vaccination program that 
required children to be certified as having received 2 doses of MMR 
vaccine before they could enter elementary school; and (3) an enhanced 
case- and laboratory-based measles surveillance system [15]. Following 
the installation of these programs, the annual measles incidence has 
declined to less than 1 per 1,000,000 of the population, and in 2006, the 
Republic of Korea became the first country in the Western Pacific 
Region (as defined by the World Health Organization [WHO]) to 
declare measles as eliminated [14, 16]. 




detected by the measles surveillance system. With the reduction in the 
number of children affected by measles, changes in the epidemiology 
of the disease are to be expected, as has been experienced in other 
countries [17, 18]. To maintain the elimination status of measles in 
Korea, ongoing efforts are needed to meet the goals of: (1) high 
vaccination coverage for 2 doses of MMR vaccine, and (2) building 
effective measles surveillance strategies [19, 20].  
Before the 2000s, surveillance of measles in Korea depended largely 
on physicians’ passive reporting of diagnosed cases. The system was 
modified in 2001 to include case-based surveillance (cases with fever, 
rash, and one or more of cough, coryza, or conjunctivitis). The 
physicians are obliged to notify the diagnosis of suspected measles 
cases to the regional Public Health Center (PHC) within seven days. In 
turn, the PHC reports to the Local Department of Health (LDH) within 
one day then the LDH should report it to the Korea Centers for Disease 
Control and Prevention (KCDC) within one day. Some, but not all, 
suspected cases were tested for measles IgM antibodies. The results of 
laboratory tests are sent back to the physician, who requested the test, 
then the physician reports the test results to the PHC or LDH; therefore, 
a delay in communicating this information was inevitable.  
In April 2006, to shorten the reporting intervals among laboratory-




which mandates nationwide sentinel laboratories to send an immediate 
notification directly to the KCDC when measles serologic testing is 
positive (Figure 1). When the KCDC receives direct notification from 
SLS, the investigation team, which is jointly operated by KCDC and 





















Figure 1. Flow-chart of the measles surveillance system in the Republic 
of Korea, 2002–2009. 
 
*
Since April 2006, sentinel laboratory surveillance of measles was 
established; sentinel laboratories testing measles antibody are mandated 











To sustain the elimination of measles, a sensitive collection and timely 
reporting of suspected cases is essential. Efforts to improve the 
timeliness of reporting must be part of a continuous process to improve 
the quality of measles surveillance systems [21, 22]. In countries where 
the incidence of measles is low, a delay in the notification process may 
occur because clinicians may have less experience in diagnosing 
measles patients without laboratory confirmation [23]. With this point 
in view, immediate reporting from laboratories to the public health 
sector may potentially shorten the information delay.  
In this report, we assessed the impact of SLS on the timeliness of 
measles reporting in Korea during the period 2002–2009. We have 
focused on the challenges related to the surveillance of measles during 
the post-elimination phase in Korea. Further, we aimed to describe the 
public health approaches that have provided the framework for the 
surveillance of measles that has been operating in Korea between years 




Materials and Methods 
1. Measles Case-based Surveillance 
The routine measles case-based surveillance system is an important tool 
for monitoring and interpreting the measles control measures in Korea. 
Since 1995, the mandatory reporting of suspected measles cases (those 
with fever, rash, and 1 of cough, coryza, and conjunctivitis [3C]) was 
required from physicians. A suspected case of measles must be reported 
to the public health centers or directly to the KCDC through the 
electronic reporting system. The electronic reporting system was 
established in 2001 to enable timely reporting of suspected cases [24]. 
In general, the Korean National Notifiable Disease Surveillance System 
operates a passive surveillance scheme with supplementary case-based 
investigation performed for all reported cases of measles. 
 
2. Case Definition and Data Collection 
We used the surveillance data collected by KCDC from 2002 to 2009 to 
evaluate the timeliness of measles surveillance in Korea. Suspected 
measles cases were classified by the WHO case definitions as follows: 
(1) clinically-confirmed was defined as cases that met the clinical case 
definition (fever, rash, and one of cough, coryza and conjunctivitis) and 
for which no adequate blood specimen was taken; and (2) laboratory-




were laboratory-confirmed (serum measles-specific IgM) [25]. We then 
analyzed the surveillance data and case investigation reports to identify 
the demographic and epidemiologic characteristics of suspected 
measles cases. The source of transmission was identified from 
epidemiologic investigation case reporting forms. The ‘source-
identified’ case was defined as the measles case patient who had 
contact with the laboratory-confirmed case at least 7–18 days before 
onset of rash. The remainder was classified as ‘source-unidentified’. 
The place of residence and seasonality were also analyzed. The analysis 
presented in this study consisted of only secondary unlinked data 
analysis; no contact with human subjects occurred. 
 
3. Data Analysis 
To evaluate the effect of SLS on the timeliness of the reporting, we first 
categorized the surveillance period into two periods: (1) Period A from 
January 2002 to March 2006, during which there was routine case-
based surveillance; and (2) Period B from April 2006 to December 
2009, during which surveillance was done in conjunction with SLS. For 
each measles case, we determined the intervals between the dates of 
symptom onset and diagnosis, physician’s notification to the LDH, and 
LDH reporting to the KCDC (Figure 1). We excluded PHC from the 




time through an electronic reporting system. Positive predictive value 
(PPV) was determined by dividing number of laboratory-confirmed 
cases by number of laboratory tests performed. 
T1 was defined as the time lag between symptom onset to diagnosis; T2 
as the time from diagnosis to notification of the LDH; and T3 as the 
time between taken by the LDH to report to the KCDC. The time limit 
of each step was defined as ‘within one day’ and the time limit for 
T1+T2+T3 was defined as ‘within three days’.  
As reported previously, the area over curve (AOC) represents the sum 
of time lag for all reports divided by the number of clinical or 
laboraotyry-confirmed cases in each period [Ref]. The difference 
between the two AOC indicates the time reduction per cases.  















1. Demographic Characteristics 
From 2002 to 2009, a total of 354 suspected measles cases were 
reported to the KCDC; 113 (32%) during Period A and 241 (68%) 
during Period B. Of the cases reported during Period A, 68% were 
clinically-confirmed, whereas 90% of cases reported during Period B 
were laboratory-confirmed (Table 1). During Period A, 60% of cases 
were male, but the male-to-female ratio was nearly equal during Period 
B. During Period A, 24% of cases reported were school-age children 
aged 6–17 years, whereas 7% of cases during Period B were in this age 
group. PPV during Period A was 10.7%, and during Period B was 
29.0%. Unlike the absence of seasonal variability observed during 
Period A, a majority of cases were reported between April and June 
during Period B. No cases had their source of infection identified 
during Period A, whereas 37% of cases that occurred during Period B 










Table 1. Demographic and epidemiologic characteristics of reported 















     
Clinically-confirmed 77 (68.1) 
 
24 (10.0) 
Laboratory-tested 337   747  
Laboratory-confirmed 36 (31.9) 
 
217 (90.0) 
PPV  (10.7)   (29.0) 
Gender 
     
M 68 (60.2) 
 
122 (50.6) 




     
<1yr 25 (22.1) 
 
82 (34.0) 
1-5yr 51 (45.1) 
 
121 (50.2) 
6-17yr 27 (23.9) 
 
17 (7.1) 




     
Metropolitan cities 61 (54.0) 
 
169 (70.0) 




     
January-March 30 (26.5) 
 
12 (5.0) 
April-June 38 (33.6) 
 
172 (71.4) 
July-September 17 (15.0) 
 
46 (19.1) 




     
Source-identified 0 (0) 
 
88 (36.5) 









Period A, from January 2002 to March 2006, under routine case-based 
measles surveillance; Period B, from April 2006 to December 2009, 
routine case-based measles surveillance plus sentinel laboratory 
surveillance. 
†
Clinically-confirmed measles cases, defined as cases that met the 
clinical case definition and for which no adequate blood specimen was 
taken; laboratory-confirmed measles cases, defined as cases that met 
the clinical case definition and were laboratory-confirmed. 
















2. Timeliness of Reporting 
Table 2 shows the proportion of measles cases reported within the 
specified time limit. For clinically-confirmed cases, the proportion of 
timely reported cases was relatively constant between Periods A and B, 
whereas for laboratory-confirmed cases the proportion for timely 
reporting at T1, T2, T3, and T1+T2+T3 increased from Period A to Period 
B. Among clinically-confirmed cases, timely reporting had decreased 
from 29% to 21%, whereas timely reporting of laboratory-confirmed 
cases had increased from 8% to 17%. Overall, among both clinically- 
and laboratory-confirmed cases, the proportion timely reporting during 
T1 and T2 was higher during Period A, whereas the proportion timely 














Table 2. Proportion of measles cases reported within time limit, by case 
















Period A Period B 
 
Period A Period B 
 























Time limit at each step was defined as ‘within one day’; time limit for 
T1+T2+T3 was defined as ‘within three days’; T1, time from symptom 
onset to diagnosis; T2, time from diagnosis to notification of the Local 
Health Department (LDH); T3, time taken for reporting from the LDH 
to the Korea Centers for Disease Control and Prevention (KCDC); 
T1+T2+T3 indicates the sum of time limits from symptom onset to 
report to KCDC. 
†
Clinically-confirmed measles cases, defined as cases that met the 
clinical case definition and for which no adequate blood specimen was 
taken; laboratory-confirmed measles cases, defined as cases that met 
the clinical case definition and were laboratory-confirmed; Period A, 
from January 2002 to March 2006, under routine case-based measles 
surveillance; Period B, from April 2006 to December 2009, routine 




The mean notification intervals according to case classification and 
surveillance periods are compared in Figure 2. For clinically-confirmed 
cases, the overall mean notification interval was similar between 
Periods A and B; however, the interval from symptom onset to 
diagnosis (T1) increased from 3.7 days to 6.3 days, respectively. For 
laboratory-confirmed cases, the overall mean notification interval 
decreased from 38.8 days to 16.4 days between Periods A and B, 
respectively. The most remarkable decrease was found in the interval 

















Figure 2. Comparative mean notification intervals by case classification 
and surveillance periods, Republic of Korea, 2002–2009. 
 
*
Period A, from January 2002 to March 2006, under routine case-
based measles surveillance; Period B, from April 2006 to December 
2009, routine case-based measles surveillance plus sentinel laboratory 
surveillance. 
†
Clinically-confirmed measles cases, defined as cases that met the 
clinical case definition and for which no adequate blood specimen was 
taken; laboratory-confirmed measles cases, defined as cases that met 
the clinical case definition and were laboratory-confirmed. 
§
T1, time from symptom onset to diagnosis; T2, time from diagnosis 
to notification of the Local Health Department (LDH); T3, time taken 




and Prevention.  
The cumulative distributions of time delay are shown in Figures 3 
and 3. The steeper curve indicates a shorter time interval between each 
step. Among clinically-confirmed cases, there were more time lags 
observed during Period B compared with Period A (Figure 3). Although 
the interval difference between LDH and KCDC (T3) was 
unremarkable, a reporting delay was observed for the intervals between 
presence of symptoms and diagnosis (T1). On the other hand, the 
differences in T1 and T2 were not significant in laboratory-confirmed 
cases (Figure 4). The intervals between symptom onset to notification 
of the KCDC (Tc), and from the LDH to the KCDC (T3) were shorter 
during Period B. Table 3 describes the time reduction between Period A 
and B among clinically-confirmed and laboratory-confirmed cases. 
Among clinically-confirmed cases, time was even more delayed during 
Period B, ranging -0.2 to -3.0 days per cases. Among laboratory-










Figure 3. Cumulative distribution of the time delay in detecting clinically-compatible measles cases (those that met the clinical 






*T1, time from symptom onset to diagnosis; T2, time from diagnosis to notification of the Local Health Department (LDH); T3, 















Figure 4. Cumulative distribution of the time delay in detecting laboratory-confirmed measles cases (those that met the clinical 






T1, time from symptom onset to diagnosis; T2, time from diagnosis to notification of the Local Health Department (LDH); T3, 















Table 3. Distribution of the time reduction in detecting clinically-confirmed and laboratory-confirmed measles cases during the 






reduction Period A Period B Period A Period B 
T1 (Symptom->Diagnosis) 3.1 5.5 -2.4 7.9 7.5 0.4 
T2 (Diagnosis -> LDH) 4.6 4.5 0.1 7.7 7.0 0.8 
T3 (LDH->KCDC) 1.5 1.6 -0.2 2.0 0.4 1.6 
Tr (Symptom->LDH) 7.8 10.8 -3.0 14.7 14.2 0.5 











Our study provides evidence that SLS shortened the time interval 
between symptom onset to notification, particularly in laboratory-
confirmed cases. Among laboratory-confirmed cases, the time intervals 
for all parameters (T1, T2, and T3) were shortened by 0.4 to 1.6 days per 
cases, resulting in a higher proportion of measles cases that were 
reported in a timely fashion. Considering the high transmissibility of 
measles in a vulnerable population, the reduction in time to report 
through establishment of SLS was meaningful. Moreover, PPV in 
Period B was even higher than that of Period A, therefore SLS 
presumably has not compromised the diagnostic accuracy in clinical 
reporting of measles, which is worrisome when maximizing timeliness 
of the surveillance. When utilized in combination with traditional case-
based surveillance, SLS improved the timeliness of the identification of 
measles cases and information flow. This finding extends other reports 
in which alternative or supplementary surveillance activities have 
shortened the time delay of disease notification. Assessment of real-
time electronic outbreak surveillance for dengue in Latin America 
showed improved timely notifications of outbreaks occurrences [26]. 
Another approach, the sentinel case-based surveillance, which was 
designed to monitor hand-foot-mouth disease from designated sentinel 




of suspected cases [27]. Moreover, several studies have shown that SLS 
reduces the time interval between diagnosis and notification. Through 
the implementation of electronic laboratory reporting of the hepatitis C 
surveillance system, an improvement in reporting timeliness was 
demonstrated in the USA [28]. In the Netherlands, the time delay was 
dramatically reduced after implementation of SLS for measles and 
hepatitis A infections [29].  
In addition, we also found that the difference in T1, which depicts 
that the interval from symptom onset to diagnosis during Period B, was 
longer than that of Period A. There are two possible main reasons for 
this difference: first, parents may seek healthcare for only a few 
children with measles symptoms because the perceived importance of 
measles would be low in the low-incidence setting; second, physicians 
are now less aware of measles in an ordinary clinical setting in Korea 
because measles is now seldom seen, resulting in decreased sensitivity 
and completeness of measles detection in the primary health care sector 
during Period B. The measles surveillance system is prone to delays in 
notification or even under-reporting in disease-eliminated countries, as 
observed in Germany and Italy [30, 31]. Nevertheless, measles has 
reemerged in countries that have already declared measles eliminated 
because new viruses are constantly being introduced from neighboring 




inadequate vaccination coverage. The delay in the diagnosis and 
notification of measles may provoke an endemic circulation of 
imported virus; then an outbreak would be expected to occur. Therefore, 
strengthening surveillance activities through laboratory confirmation 
and improving timely notification systems are an important aspect of 
sustaining measles elimination in these countries.  
From 2002 to 2009, a total of 354 suspected measles cases were 
reported to the KCDC. There was a gradual decrease from 2002 to 
2005; however, resurgence was observed in 2006 and 2007. The 
increase in reported cases in each of these 2 years mainly resulted from 
measles outbreaks. The first outbreak occurred in a preschool in 
Incheon and involved 15 confirmed cases from 152 exposed students. 
Among those 15 patients, 14 had received fewer than 2 doses of MMR 
vaccine, and measles affected 100% of children with no vaccination 
history [32]. Following the outbreak, the importance of maintaining 
high 2-dose MMR vaccination coverage and keeping accurate 
vaccination status records was emphasized. The second incident 
occurred in 2007, when multiple transmission chains of measles were 
identified, mainly in hospital settings [33]. Among 180 confirmed 
measles cases, 81 (45%) resulted from nosocomial transmission in 6 
hospitals, mostly located in Seoul and its metropolitan area. More 




vaccination. This incident helped to improve the understanding of 
measles transmission in healthcare settings and how it is related to 
community transmission; the implication was that nosocomial 
transmission of measles may precipitate the ongoing spread in the 
community setting. Although shifts in the epidemiology of infectious 
diseases are observed following an increase in vaccination coverage, 
our surveillance data did not show a noticeable age-related-shift among 
reported cases during the last 10 years.  
Measles surveillance ultimately relies on physicians to detect and 
report cases to the LDH. Because measles is now seen less often in 
Korea, physicians who began their practices after 2002 may have 
difficulty in diagnosing the disease. Although obtaining serum 
specimen is sometimes technically difficult, our data provide evidence 
that the use of laboratory testing in measles diagnosis is clearly vital 
when resources permit, especially in disease-eliminated countries. 
The benefits of laboratory surveillance include the accuracy and 
reliability of collected data. On the other hand, the price paid is an 
additional time delay. The implementation of SLS is one of many 
efforts to improve the timeliness of laboratory surveillances. Although 
there is little evidence that laboratory surveillance mitigates the 
outbreak response capacity, our data suggest that even SLS does not 




cases. Additional efforts to improve the timeliness of laboratory 
surveillance to one that is as fast as clinically-confirmed cases should 
be in place in the near future.  
Our findings are subject to several limitations. First, because we 
were unable to obtain data on the source of notification of individual 
cases (whether it was reported from routine case-based surveillance or 
from SLS), the time interval of cases reported through SLS was not 
examined separately. There was no single definition of an ‘SLS-related 
case’, and we were unable to determine the true number of such events 
to assess the sensitivity of such surveillance. Further, as observed in the 
state of Connecticut in the US, the two different surveillance methods 
may result in a different epidemiology of reported cases of an 
infectious disease [34]. Second, the change in the epidemiology of 
measles between Periods A and B may have affected the quality of the 
surveillance’s performance. Recently, there are fewer school-aged 
children detected as measles cases and more infants aged less than 12 
months are being diagnosed. Suspecting measles and obtaining a serum 
specimen from this age group may be challenging compared with older 
children with similar symptoms and signs.  
Despite these potential limitations, our observation may well 
represent an effect of SLS on the timeliness of measles surveillance. 




same timescale as the national measles surveillance data in Korea. SLS 
improved the early detection of suspected measles cases that had not 
yet been reported by physicians, therefore improving the overall 
performance of measles surveillance. Despite new challenges and 
increased responsibilities, SLS continues to provide important support 





















In conclusion, our data suggest that the SLS in Korea has allowed 
cases to be captured in a more timely fashion, and adoption of such 
surveillance measures by other countries may improve the timely 
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실험실 능동감시체계 도입에 따른  
2002-2009년 홍역 감시자료 적시성 평가 
 
배경: 본 연구는 2002년에서 2009년 사이에 발생한 홍역사례 
감시자료 및 역학조사자료를 기초로 우리나라에서 홍역을 퇴치하기 
위한 정책 중 실험실 능동감시체계 도입에 따른 적시성의 변화에 
대하여 제시하고자 하였다. 
방법: 2002-2009년 기간 동안 수집된 질병관리본부에서 확보하고 
있는 법정감염병 감시자료 및 2군 감염병 역학조사자료를 취합하여 
개별 사례를 세계보건기구 사례 기준에 맞춰 다음과 같이 
분류하였다: 1) 임상적 확진; 2) 실험실적 확진.  이후 개별 
사례들의 인구학적 분포 및 임상적 특성을 파악학도 전파 경로를 
확인한다. 홍역 양 발진 발생일을 기준으로 기간을 일반적 수동 
감시체계가 운영되던 2002년 1월부터 2006년 3월(A시기)과 
실험실 능동감시체계가 추가적으로 도입된 2006년 4월부터 
2009년 12월로 구분한다(B시기). 모든 홍역 확진 사례의 홍역 양 
발진 발생일, 의사의 진단 일시, 보건소 신고 일시, 질병관리본부 
보고 일시를 파악하여 각 단계별로 1일 이내의 시간이 소요된 경우 
적기 신고인 것으로 분류하였다. 




홍역의사환자가 보고되었다. 양 시기 간에 임상적 확진례의 적기 
신고 분율은 차이가 없었다. 하지만 B시기의 실험실적 확진례의 
적기 신고 분율은 A시기보다 높은 것으로 나타났으며 실험실 
능동감시체계는 실험실적 확진례에서의 인지기간을 평균 39일에서 
16일로 감소시켰다. 개별 사례별로는 인지기간을 실험실적 확진 
사례 당 0.4-1.8일로 감소시켰다. 
결론: 우리나라에서 실험실 능동감시체계는 신고가 되지 않은 채 
실험실 검사만 의뢰되었던 건수들의 인지기간을 단축시켰으며 
전체적인 감시체계의 질을 향상시켰다. 
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